Literature DB >> 6965697

Multimeric structure of factor VIII/von Willebrand factor in von Willebrand's disease.

D Meyer, B Obert, G Pietu, J M Lavergne, T S Zimmerman.   

Abstract

Recent studies have provided substantial evidence that F. VIII/vWF exists not only as a polymer of approximately 1 x 10(6) MW composed of 230,000 MW subunits but is further organized into a multimeric series (1 to 20 x 10(6) MW). With an immunologic technique to isolate F.VIII/vWF directly from small volumes of plasma of patients with vWD, the relative distribution and concentration of individual multimeric sets was examined by agarose gel electrophoresis in the presence of SDS. In classical vWD (type I) with decreased VIIIR:RCo, the relative distribution of multimeric forms of FVIII/vWF was comparable to normal plasma but reduced in quantity. In "variants" of vWD (type II) with undetectable VIIIR:RCo, the larger multimer subsets were absent, and the smaller one present in relatively greater concentration. Large multimers as well as VIIIR:RCo were also lacking in F.VIII/vWF prepared from normal plasma cryosupernatant. These observations suggest the existence of different molecular abnormalities of F.VIII/vWF underlying the two major types of vWD: reduced synthesis in type I and polymerization defect with resultant lack of VIIIR:RCo in type II.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6965697

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  16 in total

1.  Structural analysis of factor VIII antigen in von Willebrand disease.

Authors:  R L Nachman; E A Jaffe; C Miller; W T Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1980-11       Impact factor: 11.205

2.  The von Willebrand-syndrome.

Authors:  I Scharrer
Journal:  Blut       Date:  1983-09

3.  Von Willebrand's disease: a clinical and molecular enigma. Twelfth Annual Paul M. Aggeler Memorial Lecture.

Authors:  R L Nachman
Journal:  West J Med       Date:  1982-04

4.  Simultaneous inheritance and expression of classical haemophilia A and type IIA von Willebrand's disease.

Authors:  A C Beddall; S M Enayat; C E Williams; P E Short; F G Hill
Journal:  J Clin Pathol       Date:  1984-09       Impact factor: 3.411

5.  Collagen binding provides a sensitive screen for variant von Willebrand disease.

Authors:  Veronica H Flood; Joan Cox Gill; Kenneth D Friedman; Pamela A Christopherson; Paula M Jacobi; Raymond G Hoffmann; Robert R Montgomery; Sandra L Haberichter
Journal:  Clin Chem       Date:  2013-01-22       Impact factor: 8.327

6.  Epitope mapping by cDNA expression of a monoclonal antibody which inhibits the binding of von Willebrand factor to platelet glycoprotein IIb/IIIa.

Authors:  G Piétu; A S Ribba; G Chérel; D Meyer
Journal:  Biochem J       Date:  1992-06-15       Impact factor: 3.857

7.  Heterogeneous distribution of Weibel-Palade bodies and von Willebrand factor along the porcine vascular tree.

Authors:  J Gebrane-Younès; L Drouet; J P Caen; L Orcel
Journal:  Am J Pathol       Date:  1991-12       Impact factor: 4.307

8.  Properties of human asialo-factor VIII. A ristocetin-independent platelet-aggregating agent.

Authors:  L De Marco; S S Shapiro
Journal:  J Clin Invest       Date:  1981-08       Impact factor: 14.808

9.  The effect of Arg-Gly-Asp-containing peptides on fibrinogen and von Willebrand factor binding to platelets.

Authors:  E F Plow; M D Pierschbacher; E Ruoslahti; G A Marguerie; M H Ginsberg
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

10.  Substructure of human von Willebrand factor.

Authors:  W E Fowler; L J Fretto; K K Hamilton; H P Erickson; P A McKee
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.